G-CSF Receptor Positive Neuroblastoma Subpopulations Are Enriched in Chemotherapy-Resistant or Relapsed Tumors and Are Highly Tumorigenic
Open Access
- 30 June 2013
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 73 (13), 4134-4146
- https://doi.org/10.1158/0008-5472.can-12-4056
Abstract
Neuroblastoma is a neural crest-derived embryonal malignancy, which accounts for 13% of all pediatric cancer mortality, primarily due to tumor recurrence. Therapy-resistant cancer stem cells are implicated in tumor relapse, but definitive phenotypic evidence of the existence of these cells has been lacking. In this study, we define a highly tumorigenic subpopulation in neuroblastoma with stem cell characteristics, based on the expression of CSF3R, which encodes the receptor for granulocyte colony-stimulating factor (G-CSF). G-CSF receptor positive (aka G-CSFr+ or CD114+) cells isolated from a primary tumor and the NGP cell line by flow cytometry were highly tumorigenic and capable of both self-renewal and differentiation to progeny cells. CD114+ cells closely resembled embryonic and induced pluripotent stem cells with respect to their profiles of cell cycle, miRNA, and gene expression. In addition, they reflect a primitive undifferentiated neuroectodermal/neural crest phenotype revealing a developmental hierarchy within neuroblastoma tumors. We detected this dedifferentiated neural crest subpopulation in all established neuroblastoma cell lines, xenograft tumors, and primary tumor specimens analyzed. Ligand activation of CD114 by the addition of exogenous G-CSF to CD114+ cells confirmed intact STAT3 upregulation, characteristic of G-CSF receptor signaling. Together, our data describe a novel distinct subpopulation within neuroblastoma with enhanced tumorigenicity and a stem cell–like phenotype, further elucidating the complex heterogeneity of solid tumors such as neuroblastoma. We propose that this subpopulation may represent an additional target for novel therapeutic approaches to this aggressive pediatric malignancy. Cancer Res; 73(13); 4134–46. ©2013 AACR.Keywords
Other Versions
This publication has 51 references indexed in Scilit:
- Normal and neoplastic urothelial stem cells: getting to the root of the problemNature Reviews Urology, 2012
- Induction of the neural crest state: Control of stem cell attributes by gene regulatory, post-transcriptional and epigenetic interactionsDevelopmental Biology, 2012
- Highly Efficient miRNA-Mediated Reprogramming of Mouse and Human Somatic Cells to PluripotencyCell Stem Cell, 2011
- The Connections Between Neural Crest Development and NeuroblastomaCurrent Topics in Developmental Biology, 2011
- The miR-17-92 MicroRNA Cluster Regulates Multiple Components of the TGF-β Pathway in NeuroblastomaMolecular Cell, 2010
- Stat3 Activation Is Limiting for Reprogramming to Ground State PluripotencyCell Stem Cell, 2010
- Recent Advances in NeuroblastomaNew England Journal of Medicine, 2010
- Self-regulation of Stat3 activity coordinates cell-cycle progression and neural crest specificationThe EMBO Journal, 2009
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal EvolutionCell, 2009
- Long-term Outcomes in Survivors of Neuroblastoma: A Report From the Childhood Cancer Survivor StudyJNCI Journal of the National Cancer Institute, 2009